Article
Determinant of aggressive phenotype in metastatic hormone sensitive prostate cancer depends on an intrinsic, highly aggressive cell cluster: Integrated single- cell and whole transcriptomic analyses
2023-12-29
Abstract excerpt
<title>Abstract</title> <p>Several studies have reported that prostate cancer has a relatively favorable prognosis; however, patients with locally advanced and metastatic disease have significantly low 10-year survival rates. Although the combination of androgen deprivation therapy with docetaxel or abiraterone acetate and prednisone has become the standard treatment for metastatic hormone-sensitive prostate canc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8a087ef7-755e-57cd-97a6-c8a1737368ef
- DOI
- 10.21203/rs.3.rs-3790707/v1
